First-trimester increase in oxidative stress and risk of small-for-gestational-age fetus

BJOG. 2009 Apr;116(5):637-42. doi: 10.1111/j.1471-0528.2008.02096.x.

Abstract

Objective: Investigation of increased oxidative stress in early pregnancy and association with an increased risk of small-for-gestational-age (SGA) fetus.

Design: Longitudinal case-control study.

Setting: University Hospitals of Leicester NHS Trust, Leicester, UK.

Population: Low-risk pregnant women with no current or pre-existing medical illness were recruited at a large teaching hospital from 2004 to 2006.

Methods: Recruitment performed at the time of the dating ultrasound scan (12+/-2 weeks of gestation). Spot urine samples collected at 12+/-2 and 28+/-2 weeks of gestation were analysed for 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) by liquid chromatography with tandem mass spectrometry). SGA was defined as birthweight <10th centile based on customised centile calculator (www.gestation.net). This identified the cases (n=55), whereas controls (n=55) were mothers whose babies were appropriate for gestational age (AGA, birthweight 10th-90th centile). Statistical analysis was performed using GraphPad Prism v.5. The relationship between maternal urinary 8-oxodG at different gestations and customised SGA was investigated by nonparametric tests.

Main outcome measures: Customised SGA and AGA pregnancies.

Results: Urinary 8-oxodG concentrations were significantly increased in pregnancies with subsequent SGA compared with concentrations in normal pregnancies; 12 weeks: 2.8 (interquartile range [IQR] 1.96-3.67) versus 2.2 (IQR 1.26-3.28) pmol 8-oxodG/micromol creatinine (P=0.0007); 28 weeks: 2.21 (IQR 1.67-3.14) versus 1.68 (IQR 1.16-2.82) pmol 8-oxodG/micromol creatinine (P<0.0002). Concentrations decreased significantly between week 12 and 28 (P=0.04 and P=0.02 for controls and cases).

Conclusions: In this study, urinary 8-oxodG at 12 and 28 weeks were elevated in SGA compared with AGA pregnancies. This may reflect early placental changes predating clinical features of SGA.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Hydroxy-2'-Deoxyguanosine
  • Adolescent
  • Adult
  • Biomarkers / analysis
  • Biomarkers / urine
  • Birth Weight
  • Case-Control Studies
  • Cotinine / analysis
  • Deoxyguanosine / analogs & derivatives
  • Deoxyguanosine / urine
  • Female
  • Fetal Growth Retardation / etiology*
  • Fetal Growth Retardation / metabolism
  • Follow-Up Studies
  • Humans
  • Oxidative Stress*
  • Pregnancy / urine*
  • Pregnancy Trimester, First / urine
  • Pregnancy Trimester, Second / urine
  • Prospective Studies
  • Risk Assessment / methods
  • Saliva / chemistry
  • Smoking / adverse effects
  • Statistics, Nonparametric

Substances

  • Biomarkers
  • 8-Hydroxy-2'-Deoxyguanosine
  • Deoxyguanosine
  • Cotinine